What is William Blair’s Forecast for USPH FY2025 Earnings?

U.S. Physical Therapy, Inc. (NYSE:USPH) – Investment analysts at William Blair raised their FY2025 earnings per share estimates for shares of U.S. Physical Therapy in a research note issued to investors on Wednesday, November 12th. William Blair analyst J. Haase now forecasts that the company will post earnings of $2.64 per share for the year, up from their previous forecast of $2.45. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s FY2026 earnings at $3.03 EPS.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. The firm had revenue of $140.66 million for the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%.

USPH has been the subject of several other reports. Zacks Research upgraded U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. JPMorgan Chase & Co. initiated coverage on U.S. Physical Therapy in a report on Thursday, September 18th. They issued an “overweight” rating and a $110.00 price target for the company. Barrington Research restated an “outperform” rating and issued a $103.00 price objective on shares of U.S. Physical Therapy in a research report on Friday, October 24th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. Finally, Wall Street Zen downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $110.25.

U.S. Physical Therapy Stock Down 1.2%

Shares of NYSE USPH opened at $69.18 on Monday. The firm’s 50-day moving average is $83.64 and its two-hundred day moving average is $80.17. The company has a market capitalization of $1.05 billion, a PE ratio of 30.21, a price-to-earnings-growth ratio of 4.41 and a beta of 1.47. U.S. Physical Therapy has a 12-month low of $62.77 and a 12-month high of $101.19. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18.

U.S. Physical Therapy Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 12th. Investors of record on Monday, November 17th will be issued a $0.45 dividend. The ex-dividend date of this dividend is Monday, November 17th. This represents a $1.80 annualized dividend and a yield of 2.6%. U.S. Physical Therapy’s dividend payout ratio is currently 75.63%.

Insider Activity

In related news, CFO Carey P. Hendrickson sold 698 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $86.11, for a total value of $60,104.78. Following the completion of the sale, the chief financial officer directly owned 27,808 shares of the company’s stock, valued at $2,394,546.88. The trade was a 2.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Christopher J. Reading sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $83.53, for a total value of $167,060.00. Following the sale, the chief executive officer owned 114,088 shares in the company, valued at $9,529,770.64. The trade was a 1.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 5,061 shares of company stock worth $426,273 over the last ninety days. Insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

Large investors have recently added to or reduced their stakes in the company. CWM LLC boosted its holdings in U.S. Physical Therapy by 17.0% in the third quarter. CWM LLC now owns 968 shares of the company’s stock worth $82,000 after purchasing an additional 141 shares during the period. PNC Financial Services Group Inc. boosted its holdings in shares of U.S. Physical Therapy by 4.8% in the 3rd quarter. PNC Financial Services Group Inc. now owns 3,091 shares of the company’s stock valued at $263,000 after buying an additional 142 shares during the period. Assetmark Inc. boosted its holdings in shares of U.S. Physical Therapy by 35.7% in the 2nd quarter. Assetmark Inc. now owns 570 shares of the company’s stock valued at $45,000 after buying an additional 150 shares during the period. Amalgamated Bank grew its position in shares of U.S. Physical Therapy by 3.8% during the 3rd quarter. Amalgamated Bank now owns 4,461 shares of the company’s stock valued at $379,000 after buying an additional 162 shares during the last quarter. Finally, Osaic Holdings Inc. raised its stake in U.S. Physical Therapy by 1.6% during the second quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock worth $817,000 after acquiring an additional 166 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.